Innovation
Blue Bees Therapeutics: boosting immune cells to treat cancer
… CEA Paris-Saclay, it hopes to bring its drug candidate BB-100, based on the patented i-Ther technology, into Phase … managing partner at Auriga Partners, a venture capital management company, the two men approached the CEA and the … first round of financing with business angels, raising €218,000. Strong support The start-up Blue Bees Therapeutics …Published on: